Prior Authorization Panel Yields Insights Into Role of PBMs in Biosimilar Uptake
March 9th 2022
ArticleAt a session at the Association of Community Cancer Centers’ 2022 Annual Meeting & Cancer Center Business Summit, panelists suggested that the quest for rebates by pharmacy benefit managers (PBMs) prevents uptake on some biosimilars—and could soon bleed over into biosimilar formulary placement.